In vivo guiding inorganic nanozymes for biosensing and therapeutic potential in cancer, inflammation and microbial infections

Researchers have recently introduced some artificial enzymes based on nanomaterials that show significant catalytic activity relative to native enzymes called nanozyme. These nanozymes show superior performance than conventional catalysts and are considered as fascinating candidates for introducing the next generation of biomaterials in various industrial and biomedical fields. Recently, nanozymes have received a great deal of attention in biomedical applications due to their potential properties such as long-term stability, low cost, mass production capability, and controllable catalytic activity. Due to the intrinsic catalytic activity of nanoparticles (NPs) as nanozymes and their ability to be regulated in biomedical processes, this review paper focuses on the in vivo applications of nanozymes in biosensing and therapeutic activities. Despite the challenges and benefits of each approach, this paper attempts to provide an appropriate motivation for the classification of different nanozymes followed by their application in biomedical activities including in vivo biosensing and therapeutic potential in cancer, inflammation and microbial infections. Finally, some ongoing challenges and future perspective of nanozymes in biomedical application were surveyed. In conclusion, this paper may provide useful information regarding the development of nanozymes as promising platforms in biomedical settings due to expedited diagnosis, the advancement of multifactorial therapies and their pronounced stability.

Automated summary

Researchers have developed artificial enzymes based on nanomaterials, known as nanozymes, which exhibit significant catalytic activity compared to native enzymes. These nanozymes offer numerous advantages and are garnering increasing attention for their potential applications in the biomedical field.